Pierre Clavelou

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Ayman Tourbah, Christine Lebrun‐Frénay, Gilles Edan et al. · Multiple Sclerosis Journal · 2016 · 287 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +10

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial

Ivo N. van Schaik, Vera Bril, Nan van Geloven et al. · The Lancet Neurology · 2017 · 269 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +11

Placebo-controlled trial of rituximab in IgM anti-myelin–associated glycoprotein neuropathy

Jean‐Marc Léger, Karine Viala, Guillaume Nicolas et al. · Neurology · 2013 · 202 citations · Full text

Life Sciences, Immunology, Neurology +16

Application of the formalin test to the study of orofacial pain in the rat

Pierre Clavelou, Jacques Pajot, Radhouane Dallel et al. · Neuroscience Letters · 1989 · 201 citations

Medicine, Anesthesiology, Orofacial Pain +12

Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques

Pierre Amarenco, Stephen M. Davis, E. Jones et al. · Stroke · 2014 · 196 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17